Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuro Opps Tr. Regulatory News (EOT)

Share Price Information for Euro Opps Tr. (EOT)

Share Price is delayed by 15 minutes
Get Live Data
920.00    -5.00 (-0.54%)
Bid:
920.00
Ask:
924.00
Spread: 4.00 (0.435%)
Market Cap: £429.27m
EOT Live PriceLast checked at - London Stock Exchange

Intraday Euro Opps Tr. Share Chart

Director Declaration

2 May 2025 17:08

RNS Number : 3150H
European Opportunities Trust PLC
02 May 2025
 

EUROPEAN OPPORTUNITIES TRUST PLC (the 'Company')

Legal Entity Identifier: 549300XN7RXQWHN18849

 

Director Declaration

 

In accordance with UK Listing Rule 6.4.9, the Company announces that Ms Neeta Patel CBE has been appointed as a non-executive director of Maven Renovar VCT PLC with effect from 1 May 2025.

 

For further information, please contact:

 

Devon Equity Management Limited

Company Secretaries to European Opportunities Trust PLC

Richard Pavry

enquiries@devonem.com

020 3985 0445

 

2 May 2025

 

www.europeanopportunitiestrust.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNATMFTMTMMBFA
Date   Source Headline
7th Apr 202610:07 amRNSNet Asset Value(s)
1st Apr 202610:43 amRNSTotal Voting Rights
1st Apr 20269:58 amRNSNet Asset Value(s)
31st Mar 20269:50 amRNSNet Asset Value(s)
30th Mar 202610:44 amRNSNet Asset Value(s)
27th Mar 202610:46 amRNSNet Asset Value(s)
26th Mar 202610:52 amRNSNet Asset Value(s)
25th Mar 20269:54 amRNSNet Asset Value(s)
23rd Mar 20269:45 amRNSNet Asset Value(s)
20th Mar 202610:13 amRNSNet Asset Value(s)
19th Mar 202610:32 amRNSNet Asset Value(s)
18th Mar 202610:04 amRNSNet Asset Value(s)
17th Mar 20269:57 amRNSNet Asset Value(s)
16th Mar 202610:48 amRNSNet Asset Value(s)
13th Mar 202610:27 amRNSNet Asset Value(s)
12th Mar 20269:38 amRNSNet Asset Value(s)
11th Mar 202610:34 amRNSNet Asset Value(s)
10th Mar 202610:39 amRNSNet Asset Value(s)
9th Mar 20269:58 amRNSNet Asset Value(s)
9th Mar 20269:06 amRNSHolding(s) in Company
6th Mar 202610:20 amRNSNet Asset Value(s)
5th Mar 20269:46 amRNSNet Asset Value(s)
4th Mar 20269:58 amRNSNet Asset Value(s)
3rd Mar 20263:06 pmRNSPortfolio Update
3rd Mar 202610:49 amRNSNet Asset Value(s)
2nd Mar 202611:04 amRNSNet Asset Value(s)
2nd Mar 20269:37 amRNSTotal Voting Rights
27th Feb 20269:47 amRNSNet Asset Value(s)
26th Feb 202610:06 amRNSNet Asset Value(s)
25th Feb 20269:58 amRNSNet Asset Value(s)
24th Feb 202610:25 amRNSNet Asset Value(s)
23rd Feb 202610:22 amRNSNet Asset Value(s)
20th Feb 20269:39 amRNSNet Asset Value(s)
19th Feb 20269:52 amRNSNet Asset Value(s)
18th Feb 20264:34 pmRNSHolding(s) in Company
18th Feb 20269:41 amRNSNet Asset Value(s)
17th Feb 20269:59 amRNSNet Asset Value(s)
17th Feb 20267:00 amRNSHalf-year Financial Report
16th Feb 202610:42 amRNSNet Asset Value(s)
13th Feb 202610:54 amRNSNet Asset Value(s)
13th Feb 20267:00 amRNSStrategic Review
12th Feb 202610:13 amRNSNet Asset Value(s)
11th Feb 202610:03 amRNSNet Asset Value(s)
10th Feb 20269:48 amRNSNet Asset Value(s)
9th Feb 20262:40 pmRNSPortfolio Update
9th Feb 20269:47 amRNSNet Asset Value(s)
6th Feb 20269:54 amRNSNet Asset Value(s)
5th Feb 202610:01 amRNSNet Asset Value(s)
4th Feb 202611:34 amRNSNet Asset Value(s)
3rd Feb 202611:02 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.